ArticlePharmacoEconomics2004

Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France.

Jean-Pierre Marissal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.